
MIMETAS, a leading organ-on-a-chip company, has announced the publication of a new peer-reviewed study that marks a major advance in cardiovascular disease research. The study, titled “Microfluidic artery-on-a-chip model with unidirectional gravity-driven flow for high-throughput applications”, presents a novel 3D…










